Art. 3 Decision_act (EU) 2003/316

In force

During the period 1 January to 31 December 2003 the following rules shall apply:

1.

the allocation of essential medical use quotas for chlorofluorocarbons 11, 12, 113, 114 and 115 shall be to the companies indicated in Annex II;

2.

the allocation of essential laboratory use quotas for chlorofluorocarbons 11, 12, 113, 114 and 115 and other fully halogenated chlorofluorocarbons shall be to the companies indicated in Annex III;

3.

the allocation of essential laboratory use quotas for halons shall be to the companies indicated in Annex IV;

4.

the allocation of essential laboratory use quotas for carbon tetrachloride shall be to the companies indicated in Annex V;

5.

the allocation of essential laboratory use quotas for 1,1,1-trichloroethane shall be to the companies indicated in Annex VI;

6.

the allocation of essential laboratory use quotas for hydrobromofluorocarbons shall be to the companies indicated in Annex VII;

7.

the allocation of essential laboratory use quotas for bromochloromethane shall be to the companies indicated in Annex VIII;

8.

the essential use quotas for chlorofluorocarbons 11, 12, 113, 114 and 115, other fully halogenated chlorofluorocarbons, carbon tetrachloride, 1,1,1-trichloroethane, hydrobromofluorocarbons and bromochloromethane shall be as set out in Annex IX.